BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 26918446)

  • 1. A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results of a prospective multicentric clinical study.
    Kang M; Long J; Li G; Yan H; Feng G; Liu M; Zhu J; Wang R
    Oncotarget; 2016 Mar; 7(12):15252-61. PubMed ID: 26918446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value and Grading of MRI-Based T Category in Patients With Nasopharyngeal Carcinoma Without Lymph Node Metastasis Undergoing Intensity-Modulated Radiation Therapy.
    Chen YP; Tang LL; Zhang WN; Mao YP; Chen L; Sun Y; Liu LZ; Li WF; Liu X; Zhou GQ; Guo R; Mai HQ; Shao JY; Lin AH; Li L; Ma J
    Medicine (Baltimore); 2015 Oct; 94(43):e1624. PubMed ID: 26512556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy?
    Chen Y; Hu XF; Wang Y; Chen HY; Yang L; Liu LZ; Cui CY; Liu DS; Liang SB
    BMC Cancer; 2015 Apr; 15():305. PubMed ID: 25903652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Model of Death and Distant Metastasis for Nasopharyngeal Carcinoma Patients Receiving 3DCRT/IMRT in Nonendemic Area of China.
    Zang J; Li C; Zhao LN; Wang JH; Xu M; Luo SQ; Hitchcock YJ; Shi M
    Medicine (Baltimore); 2016 May; 95(21):e3794. PubMed ID: 27227955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectively sparing of the supraclavicular area during intensity-modulated radiotherapy in nasopharyngeal carcinoma: A double-center observation study.
    Guo Q; Lu T; Huang W; Xu H; Zhang Q; Xiao Y; Zhong J; Xie H; Chen J; Zong J; Gong X; Pan J; Li J; Lin S
    Radiother Oncol; 2024 Mar; 192():110086. PubMed ID: 38184146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary tumor inflammation in gross tumor volume as a prognostic factor for nasopharyngeal carcinoma patients.
    Peng H; Chen L; Tang LL; Zhang Y; Li WF; Mao YP; Zhang F; Guo R; Liu LZ; Tian L; Lin AH; Sun Y; Ma J
    Oncotarget; 2016 Mar; 7(12):14963-72. PubMed ID: 26934649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Size Threshold for MRI-Detected Retropharyngeal Lymph Nodes to Predict Outcomes in Nasopharyngeal Carcinoma: A Two-Center Study.
    Zhu Y; Luo C; Zhou S; Li H; Liu L; Kou KI; Lei F; Zhang G; Cao D; Liang Z
    AJR Am J Roentgenol; 2024 Jan; 222(1):e2329984. PubMed ID: 37753859
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinoma.
    Cui L; Chen Z; Zeng F; Jiang X; Han X; Yuan X; Wu S; Feng H; Lin D; Lu W; Liu X; Peng X; Yu B
    BMC Cancer; 2023 Nov; 23(1):1146. PubMed ID: 38007428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constructing an individualized surveillance framework for nasopharyngeal carcinoma based on a dynamic risk-adapted approach.
    Lu T; Xu H; Huang W; Zong J; Pan C; Huang C; Xiao Y; Chen B; Li J; Pan J; Lin S; Guo F; Guo Q
    Radiother Oncol; 2023 Aug; 185():109716. PubMed ID: 37207875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of paranasal sinus invasion on advanced nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: the validity of advanced T stage of AJCC/UICC eighth edition staging system.
    Wang Y; Zhao J; Zhao Y; Yang Z; Lei M; Li Z; Wei R; Chen D; He Y; Shen L
    Cancer Med; 2018 Jul; 7(7):2826-2836. PubMed ID: 29717544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma.
    Du XJ; Wang GY; Zhu XD; Han YQ; Lei F; Shen LF; Yang KY; Chen L; Mao YP; Tang LL; Li L; Wu Z; Xu GQ; Zhou Q; Huang J; Guo R; Zhang Y; Liu X; Zhou GQ; Li WF; Xu C; Lin L; Chen YP; Chen FP; Liang XY; Chen SY; Li SQ; Cui CY; Li JB; Ren J; Chen MY; Liu LZ; Sun Y; Ma J
    Cancer Cell; 2024 Mar; 42(3):464-473.e3. PubMed ID: 38242125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life in patients with nasopharyngeal carcinoma receiving IMRT vs IMPT: a multicenter prospective longitudinal study.
    Chung CF; Huang BS; Wang YM; Huang YT; Chen SC
    Support Care Cancer; 2024 Mar; 32(3):203. PubMed ID: 38430411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitive radiotherapy for nasopharyngeal carcinoma in Japan: analysis of cases in the National Head and Neck Cancer Registry from 2011 to 2014.
    Koide Y; Kodaira T; Kitayama M; Kawakita D; Kirita T; Yoshimoto S; Nakamizo M; Nibu KI
    Jpn J Clin Oncol; 2024 Jan; 54(1):54-61. PubMed ID: 37781753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting TNM staging for EBV-related nasopharyngeal carcinoma.
    Dennis M; Haddad R
    Cancer Cell; 2024 Mar; 42(3):333-334. PubMed ID: 38402611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum ferritin predicted prognosis in patients with nasopharyngeal carcinoma.
    Chen Z; Liang Z; Chen K; Zhang S; Huang X; Wu G; Zhu X
    Sci Rep; 2024 Feb; 14(1):4311. PubMed ID: 38383702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trajectories of fear of progression in nasopharyngeal carcinoma patients receiving proton and heavy ion therapy.
    Zheng M; Wang S; Zhu Y; Wan H
    Support Care Cancer; 2023 Oct; 31(12):630. PubMed ID: 37843679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposal of a modified subclassification system for stage III colorectal cancer: A multi-institutional retrospective analysis.
    Shinto E; Ike H; Hida JI; Kobayashi H; Hashiguchi Y; Hase K; Kishi Y; Ueno H; Sugihara K
    Ann Gastroenterol Surg; 2020 Nov; 4(6):667-675. PubMed ID: 33319157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure Patterns of Recurrence and Metastasis After Intensity-Modulated Radiotherapy in Patients With Nasopharyngeal Carcinoma: Results of a Multicentric Clinical Study.
    Chen S; Yang D; Liao X; Lu Y; Yu B; Xu M; Bin Y; Zhou P; Yang Z; Liu K; Wang R; Zhao T; Kang M
    Front Oncol; 2021; 11():693199. PubMed ID: 35223448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Epstein-Barr Virus in Modulating Key Tumor Suppressor Genes in Associated Malignancies: Epigenetics, Transcriptional, and Post-Translational Modifications.
    Fierti AO; Yakass MB; Okertchiri EA; Adadey SM; Quaye O
    Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Factors for Overall Survival in Nasopharyngeal Cancer and Implication for TNM Staging by UICC: A Systematic Review of the Literature.
    Chiang CL; Guo Q; Ng WT; Lin S; Ma TSW; Xu Z; Xiao Y; Li J; Lu T; Choi HCW; Chen W; Chau ESC; Luk PHY; Huang SH; O'Sullivan B; Pan J; Lee AWM
    Front Oncol; 2021; 11():703995. PubMed ID: 34540670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.